Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tripadvisor Inc Common Stock (TRIP) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Tripadvisor Inc Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Tripadvisor Inc Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Tripadvisor Inc Common Stock trades at $8.93 (market cap $1.02B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Vir Biotechnology Inc. Common Stock is the larger of the two by market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Tripadvisor Inc Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tripadvisor Inc Common Stock for 58 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

TRIPVIR
Market Cap
$1.02B$1.80B
Volume
1,973,7361,782,836
Sector
Consumer CyclicalHealth
52-Week High
$16.72$11.78
52-Week Low
$8.04$5.12
Typical Hold Time
58 Days0 Days
Enterprise Value
$1.08B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Tripadvisor Inc Common Stock

TripAdvisor (TRIP) trades at $8.93, up 2.41% today but near its 52-week low of $8.27. The stock shows neutral technical signals with bearish moving averages. Fundamentally, revenue grew to $1.89B in 2025 with a net income margin of 2.11%, though recent quarters show earnings misses. The P/E ratio of 218.5 reflects high valuation relative to earnings, while P/S of 0.57 suggests reasonable sales valuation. Analyst sentiment is mixed with 62.5% hold ratings.

The outlook remains cautious due to competitive pressures from AI travel tools and uneven demand. Upside exists if Viator performance improves and TheFork sale completes, but risks include persistent earnings volatility and market share erosion. The consensus price target of $13.58 offers 52% potential upside from current levels.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TRIP

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Tripadvisor Inc Common Stock

TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).

Read more on TRIP →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →